Validity and Responsiveness of the Manchester Fatigue Scale in Post-COVID

Objective: This study investigates the Manchester COPD Fatigue Scale's (MCFS) validity and responsiveness in individuals after hospitalization due to COVID-19.Methods: A longitudinal observational study included 53 adults diagnosed with COVID-19. Modified Medical Research Council dyspnea scale...

Descripción completa

Detalles Bibliográficos
Autores: Müller, Mara Galdino, Americano, Caroline Valle, Mourão Júnior , Carlos Alberto, Corrêa, Cyntia Pace Schmitz, Azevedo, Felipe Meirelles de, Polato, Rafaella, Cabral , Leandro Ferracini, Oliveira , Cristino Carneiro, José , Anderson, malaguti, Carla
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:Brasil
Institución:Universidade Nove de Julho (UNINOVE)
Repositorio:Revista Conscientiae Saúde (Online)
Idioma:portugués
OAI Identifier:oai:ojs.periodicos.uninove.br:article/26134
Acceso en línea:https://periodicos.uninove.br/saude/article/view/26134
Access Level:acceso abierto
Palabra clave:Fatigue
Post-Acute COVID-19 Syndrome
Symptom Assessment
Fadiga
Síndrome de COVID-19 pós-aguda
Avaliação de sintomas
Descripción
Sumario:Objective: This study investigates the Manchester COPD Fatigue Scale's (MCFS) validity and responsiveness in individuals after hospitalization due to COVID-19.Methods: A longitudinal observational study included 53 adults diagnosed with COVID-19. Modified Medical Research Council dyspnea scale (mMRC), Six-Minute Step Test (6MST), Saint George's Respiratory Questionnaire (SGRQ), and Hospital Anxiety and Depression Scale (HADS) were assessed. The measurement properties tested were concurrent, convergent, discriminant validities, and responsiveness.Results: The MCFS showed concurrent, convergent, and discriminant validity, with moderate to strong significant correlations with fatigue (rs=0.57), symptoms (rs=-0.27), exercise performance (rs=0.39), depression (rs=0.67), and dyspnea (rs=0.44) measures. The instrument exhibited internal responsiveness with reduced fatigue scores three months after hospital discharge (median total score from 14.5 to 5.0,p<0.001). External responsiveness was shown through associations between MCFS scores and dyspnea changes. Conclusion: The MCFS is a valid and responsive tool for physicians and researchers in effectively identifying, monitoring, and managing post-COVID-19 fatigue.

Similares en LA Referencia